Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Myristic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 known ✓ | P03372 | 1/20 | 0.90 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.90 |
| ▸ | PPARG | P37231 | 7/20 | 0.90 |
| ▸ | PPARD | Q03181 | 7/20 | 0.90 |
| ▸ | PPARA | Q07869 | 7/20 | 0.90 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.90 |
| ▸ | TSHR | P16473 | 4/20 | 0.90 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.90 |
| ▸ | FABP4 | P15090 | 3/20 | 0.90 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.90 |
| ▸ | TLR2 | O60603 | 2/20 | 0.90 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.90 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.90 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.90 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.90 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.90 |
| ▸ | MEN1 | O00255 | 1/20 | 0.90 |
| ▸ | PDE4A | P27815 | 1/20 | 0.90 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.90 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Stearic Acid SCHEMBL8579196 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Stearic Acid SCHEMBL60794 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL1477647 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL1235050 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Palmitic Acid SCHEMBL585535 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Myristic Acid SCHEMBL6253364 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptanoate SCHEMBL5078565 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Heptanoate SCHEMBL385003 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Octanoic Acid SCHEMBL5136070 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 | |
| Decanoic Acid SCHEMBL386211 | 1.00 | GPR84 (0.90) | GPR84PPARGPPARDPPARAHDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 895 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115651906-A | In-vitro bionic tissue evaluation model for introducing immunity into bone repair and application thereof | 广东省科学院生物与医学工程研究所 | 2023-01-31 | — | — | CN | claimed |
| EP-3998084-A1 | CANCER CELL-TARGETED DRUG DELIVERY CARRIER AND COMPOSITION FOR PROMOTING PHOTO-THERMAL TREATMENT EFFECTS, BOTH OF WHICH CONTAIN M1 MACROPHAGES AS ACTIVE INGREDIENT | Korea University Research and Business Foundation (KR) | 2022-05-18 | — | — | EP | claimed |
| CN-106580817-A | Antibacterial hand sanitizer based on titanium dioxide/activated carbon composite material | 青岛海之星生物科技有限公司 | 2017-04-26 | — | — | CN | claimed |
| US-20160158410-A1 | POLYSACCHARIDE HYDROGELS FOR INJECTION WITH TUNABLE PROPERTIES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2016-06-09 | — | — | US | claimed |
| EP-3024439-A1 | POLYSACCHARIDE HYDROGELS FOR INJECTION WITH TUNABLE PROPERTIES | Albert-Ludwigs-Universität Freiburg (DE) | 2016-06-01 | — | — | EP | claimed |
| US-20160040126-A1 | REGULATION OF DIFFERENTIATION INTO DOPAMINERGIC NEURONS BY METALLOPROTEASE | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION (KR) | 2016-02-11 | — | — | US | claimed |
| WO-2015011104-A1 | POLYSACCHARIDE HYDROGELS FOR INJECTION WITH TUNABLE PROPERTIES | ALBERT-LUDWIGS-UNIVERSITÄT FREIBURG (DE) | 2015-01-29 | — | — | WO | claimed |
| WO-2014042292-A1 | COMPOSITION COMPRISING PROTEIN KINASE C ACTIVATOR FOR PROMOTING STEM CELL ADHESION, AND METHOD FOR PROMOTING STEM CELL ADHESION | 연세대학교 산학협력단 (KR) | 2014-03-20 | — | — | WO | claimed |
| WO-2013125878-A1 | REGULATION OF DIFFERENTIATION INTO DOPAMINERGIC NEURONS BY METALLOPROTEASE | 고려대학교산학협력단 (KR) | 2013-08-29 | — | — | WO | claimed |
| EP-1003782-B1 | LIGAND FOR HERPES SIMPLEX VIRUS ENTRY MEDIATOR AND METHODS OF USE | JOLLA INST ALLERGY IMMUNOLOG (US) | 2011-01-12 | — | — | EP | claimed |
| US-20020115212-A1 | Enchanced PKR expression and cytokine production | GENETROL BIOTHERAPEUTICS, INC. | 2002-08-22 | — | — | US | claimed |
| WO-2002062837-A2 | CELLS WITH ENHANCED PKR EXPRESSION FOR INCREASING CYTOKINE PRODUCTION | GENETROL BIOTHERAPEUTICS, INC. (US) | 2002-08-15 | — | — | WO | claimed |
| US-6159712-A | Methods for enhancing the production of interferon in cell culture | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-12-12 | — | — | US | claimed |
| US-6071889-A | INDUCING THE PROLIFERATION OF A MULTIPOTENT NEURAL STEM CELL COMPRISING A CULTURE MEDIUM SUPPLEMENTED WITH ATLEAST ONE GROWTH FACTROR, PREFERABLEY EPIDERAM GROWTH FACTOR OR TRANSFORMING GROWTH FACTOR ALPHA | NEUROSPHERES HOLDINGS LTD. (CA) | 2000-06-06 | — | — | US | claimed |
| EP-0410751-B1 | Gene encoding M-CSF and related recombinant systems thereof | DENKI KAGAKU KOGYO KK (JP) | 1996-04-10 | — | — | EP | claimed |
| EP-0282160-B1 | A method of obtaining a retrovirus-containing fraction from retrovirus-containing cells | UNIV LIVERPOOL (GB) | 1995-05-10 | — | — | EP | claimed |
| EP-0398924-A1 | HISTAMINE RELEASE INHIBITORY FACTOR AND PREPARATIONS THEREFORE. | UNIV TEXAS (US) | 1990-11-28 | — | — | EP | claimed |
| WO-1989006545-A1 | HISTAMINE RELEASE INHIBITORY FACTOR AND PREPARATIONS THEREFORE | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 1989-07-27 | — | — | WO | claimed |
| EP-0282160-A2 | A method of obtaining a retrovirus-containing fraction from retrovirus-containing cells | THE UNIVERSITY OF LIVERPOOL (GB) | 1988-09-14 | — | — | EP | claimed |
| US-4683199-A | Interleukin-2 dependent cytotoxic T-cell clones | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1987-07-28 | — | — | US | claimed |